
Food and drink giant Nestlé has confirmed it is in motion to scoop up the remaining shares in Californian biotech …

Daiichi Sankyo has unveiled promising new benefit for Nilemdo (bempedoic acid) at the ESC Congress 2020 over the weekend for …

Sanofi is halting clinical trials treating serious COVID-19 patients with its Kevzara drug after data on its efficacy proved inconclusive.The …

AstraZeneca took the opportunity at the digital ESC Congress 2020 over the weekend to reveal promising new Phase 3 data …

MSD has lifted the lid on plans to build a $1.3 billion research centre in central London.The London Discovery Research …

Australia has signed its first deal to secure doses of a potential COVID-19 vaccine for its citizens, inking a partnership …

Poseida’s Phase 1 trial that used an investigational CAR T therapy for treating prostate cancer has been suspended due to …

Bristol Myers Squibb has scooped up the sole rights to the interleukin-12 (IL-12) immunotherapy programme of Massachusetts-based biotech Dragonfly Therapeutics, …

Amazon has entered the pharmaceutical market by launching ‘Amazon Pharmacy’ in India.

It’s good news for Mesoblast as an expert FDA panel gave a glowing recommendation for the approval in the US …

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …

New research has warned that minority groups and people of colour are underrepresented in current trials for COVID-19 therapies, despite …

Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to …

Bayer is set to acquire UK-based biotech KaNDy Therapeutics, assimilating the firm’s women’s healthcare development portfolio in a newly announced …

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …